5 completed, 1 not yet recruiting, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Not yet recruiting 1, Unknown 1 |
Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage | Phase 4 | Not yet recruiting | West China Hospital | 672 | 2023-10-01 | 2023-09-28 |
| Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy | Phase 4 | Unknown | Yanqing Li | 120 | 2017-05-30 | 2017-05-03 |
| The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients Ilaprazole, Amoxicillin, Clarithromycin - Peptic Ulcer | Phase 4 | Completed | Kyungpook National University Hospital | 50 | 2016-03-02 | 2018-08-09 |
| Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Ilaprazole, Rabeprazole - Gastric Cancer | Phase 4 | Completed | Il-Yang Pharm. Co., Ltd. | 176 | 2015-12-01 | 2020-07-31 |
| Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection Ilaprazole + Amoxicillin - Helicobacter Infections | Phase 4 | Completed | Il-Yang Pharm. Co., Ltd. | 90 | 2014-12-01 | 2015-11-03 |
| Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori Ilaprazole, Esoprazole - Helicobacter Pylori Eradication | Phase 4 | Completed | Livzon Pharmaceutical Group Inc. | 2014-09-01 | 2016-08-19 | |
| The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker Ilaprazole - Gastrointestinal Subepithelial Tumors | Phase 4 | Completed | Yonsei University | 20 | 2014-07-01 | 2019-03-22 |
Gastroesophageal Reflux (1) · Gastrointestinal Hemorrhage (1) · Helicobacter Infections (1) · Liver Cirrhosis (1) · Peptic Ulcer (1) · Stomach Neoplasms (1)
Il-Yang Pharm. Co., Ltd. (2) · Kyungpook National University Hospital (1) · Livzon Pharmaceutical Group Inc. (1) · West China Hospital (1) · Yanqing Li (1) · Yonsei University (1)
South Korea (3)
ChangSeok Bang, MD, PhD (1) · Li Yanqing, MD, PhD (1) · Seong Woo Jeon (1) · YoonJeong Lim, MD, PhD (1)